C8A]^{*H]T}OWVIZ6KS5DO[LE53F;R
SYSTEM PROCESSING...
C8A]^{*H]T}OWVIZ6KS5DO[LE53F;R
SYSTEM PROCESSING...
Posted: 2025-04-17 14:45:45 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-17 14:46:23 UTC
Verified By
Rollup News
A study reveals that Ozempic users face a doubled risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a condition leading to sudden vision loss in one eye. Researchers caution against immediate cessation of Ozempic treatment, emphasizing the importance of treating Type 2 diabetes while considering the associated risks.
Ozempic doubles the risk of NAION, leading to sudden vision loss.
NAION is considered the most common cause of sudden vision loss in people older than 50.
Increase in NAION cases since Ozempic introduction in 2018.
Researchers caution against immediate cessation of Ozempic treatment.
Increased risk of NAION with Ozempic use.
Potential for severe and permanent vision loss.
Determining the mechanism behind Ozempic-related NAION.
Identifying patients at higher risk of experiencing NAION.